Transmedics Group Stock Price Prediction
| TMDX Stock | USD 78.58 2.54 3.34% |
Oversold Vs Overbought
29
Oversold | Overbought |
EPS Estimate Next Quarter 0.28 | EPS Estimate Current Year 0.973 | EPS Estimate Next Year 1.537 | Wall Street Target Price 123.875 | EPS Estimate Current Quarter 0.29 |
Using TransMedics hype-based prediction, you can estimate the value of TransMedics Group from the perspective of TransMedics response to recently generated media hype and the effects of current headlines on its competitors.
TransMedics Group Hype to Price Pattern
Investor biases related to TransMedics' public news can be used to forecast risks associated with an investment in TransMedics. The trend in average sentiment can be used to explain how an investor holding TransMedics can time the market purely based on public headlines and social activities around TransMedics Group. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of TransMedics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about TransMedics.
The fear of missing out, i.e., FOMO, can cause potential investors in TransMedics to buy its stock at a price that has no basis in reality. In that case, they are not buying TransMedics because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
TransMedics after-hype prediction price | USD 81.11 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
TransMedics |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of TransMedics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
TransMedics After-Hype Price Prediction Density Analysis
As far as predicting the price of TransMedics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in TransMedics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of TransMedics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
TransMedics Estimiated After-Hype Price Volatility
In the context of predicting TransMedics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on TransMedics' historical news coverage. TransMedics' after-hype downside and upside margins for the prediction period are 76.07 and 86.15, respectively. We have considered TransMedics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
TransMedics is very steady at this time. Analysis and calculation of next after-hype price of TransMedics Group is based on 3 months time horizon.
TransMedics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as TransMedics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading TransMedics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with TransMedics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.06 | 5.10 | 2.31 | 0.52 | 10 Events / Month | 10 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
78.58 | 81.11 | 3.22 |
|
TransMedics Hype Timeline
TransMedics Group is at this time traded for 78.58. The entity has historical hype elasticity of 2.31, and average elasticity to hype of competition of -0.52. TransMedics is forecasted to increase in value after the next headline, with the price projected to jump to 81.11 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 3.22%, whereas the daily expected return is at this time at -1.06%. The volatility of related hype on TransMedics is about 1046.92%, with the expected price after the next announcement by competition of 78.06. TransMedics Group currently holds 515.95 M in liabilities with Debt to Equity (D/E) ratio of 0.36, which is about average as compared to similar companies. Given the investment horizon of 90 days the next forecasted press release will be in about 10 days. Check out TransMedics Basic Forecasting Models to cross-verify your projections.TransMedics Related Hype Analysis
Having access to credible news sources related to TransMedics' direct competition is more important than ever and may enhance your ability to predict TransMedics' future price movements. Getting to know how TransMedics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how TransMedics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| INSP | Inspire Medical Systems | (9.85) | 11 per month | 2.62 | (0.02) | 4.95 | (5.08) | 16.85 | |
| NARI | Inari Medical | 0.21 | 9 per month | 2.19 | 0.02 | 6.30 | (3.87) | 19.78 | |
| INMD | InMode | (0.27) | 9 per month | 2.71 | 0.07 | 4.91 | (5.21) | 17.38 | |
| PODD | Insulet | (0.59) | 10 per month | 0.64 | 0.21 | 3.36 | (1.72) | 12.33 | |
| SILK | Silk Road Medical | (0.05) | 9 per month | 0.03 | (0.43) | 0.41 | (0.33) | 1.14 | |
| LUNG | Pulmonx Corp | (0.05) | 7 per month | 4.10 | (0.01) | 9.00 | (6.89) | 20.52 | |
| OFIX | Orthofix Medical | 0.12 | 9 per month | 2.03 | 0.04 | 3.90 | (3.85) | 12.11 | |
| TELA | Tela Bio | 0.12 | 5 per month | 2.69 | (0) | 6.43 | (4.83) | 15.40 | |
| CVRX | CVRx Inc | 0.22 | 9 per month | 3.55 | 0.15 | 12.31 | (8.22) | 41.08 | |
| NPCE | Neuropace | 0.13 | 10 per month | 3.00 | 0.09 | 9.73 | (6.19) | 35.38 | |
| DCTH | Delcath Systems | 0.14 | 7 per month | 3.05 | 0.07 | 7.57 | (4.00) | 25.52 | |
| SWAV | Shockwave Medical | 0.00 | 0 per month | 2.04 | (0.03) | 3.76 | (3.16) | 16.22 | |
| PEN | Penumbra | 3.38 | 9 per month | 1.94 | 0.09 | 4.63 | (2.90) | 12.89 | |
| MASI | Masimo | (0.33) | 12 per month | 1.07 | 0.18 | 4.84 | (2.30) | 14.35 |
TransMedics Additional Predictive Modules
Most predictive techniques to examine TransMedics price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for TransMedics using various technical indicators. When you analyze TransMedics charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About TransMedics Predictive Indicators
The successful prediction of TransMedics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as TransMedics Group, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of TransMedics based on analysis of TransMedics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to TransMedics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to TransMedics's related companies. | 2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 1.37 | 8.44 | 6.88 | 7.23 | Days Of Inventory On Hand | 595.8 | 266.82 | 184.46 | 175.24 |
Story Coverage note for TransMedics
The number of cover stories for TransMedics depends on current market conditions and TransMedics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that TransMedics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about TransMedics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
TransMedics Short Properties
TransMedics' future price predictability will typically decrease when TransMedics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of TransMedics Group often depends not only on the future outlook of the potential TransMedics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. TransMedics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 32.5 M | |
| Cash And Short Term Investments | 394.8 M |
Additional Tools for TransMedics Stock Analysis
When running TransMedics' price analysis, check to measure TransMedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TransMedics is operating at the current time. Most of TransMedics' value examination focuses on studying past and present price action to predict the probability of TransMedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TransMedics' price. Additionally, you may evaluate how the addition of TransMedics to your portfolios can decrease your overall portfolio volatility.